Category: 2022

New method of assessing LEND’s effectiveness evaluates five-year outcome of trainees

From physicians to speech language pathologists, to social workers and nutritionists, there are a wide range of professionals that help to support the services and supports that help people with IDD to thrive.

The Bone Dysplasia Clinic’s many decades of helping families

The start of the Waisman Center’s Bone Dysplasia Clinic was a case of serendipity. It was 1980 and Richard Pauli, MD, a pediatric geneticist, had just arrived at UW-Madison. Over the course of the year, Pauli settled into his new role at UW Hospital. Then in 1981, he was approached by radiologist Len Langer, MD, with a strange request.

Cancer drug may be treatment option for fragile X syndrome

A newer cancer drug may also be a treatment option for a leading intellectual and developmental disability. Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.

El programa de capacitación posdoctoral en Waisman equipa a una nueva generación de científicos en la investigación de discapacidades intelectuales y del desarrollo

Durante más de 26 años, el Programa de Capacitación Postdoctoral en Investigación de Discapacidades Intelectuales y del Desarrollo del centro ha ayudado a dar forma a las carreras y trayectorias de 53 investigadores postdoctorales a través de capacitación multidisciplinaria en investigación social, epidemiológica, conductual y bioconductual sobre discapacidades intelectuales y del desarrollo (IDD, en inglés).

Postdoctoral program equips a new generation of scientists in IDD research

For more than 26 years, the center’s Postdoctoral Training Program in Intellectual and Developmental Disabilities Research has helped shape the careers and research paths of 53 postdoctoral researchers through multidisciplinary training in social, epidemiological, behavioral and biobehavioral research on intellectual and developmental disabilities (IDD).

Informe anual: Terapia de grupo del programa de tratamiento del autismo

Un vistazo al nuevo programa de terapia de autismo grupal del Waisman Center Por Emily Leclerc, Escritora Científica, Waisman Center Nota: Lizzie Oster prefiere que se refieran a ella como persona autista en lugar de persona con autismo. El lenguaje de esta pieza refleja esa preferencia. Elizabeth “Lizzie” Oster tenía 16 años cuando fue diagnosticada …

New autism group therapy series changes lives

Elizabeth “Lizzie” Oster was 16 when she was diagnosed with autism. Most autistic people are diagnosed young, typically between the ages of four and five according to the Centers for Disease Control and Prevention, and can start treatment and therapy early. For Lizzie, this wasn’t how it went.

Two Waisman investigators named research professors

Two Waisman investigators were recently awarded a new professor title track at UW-Madison.

Una investigación pionera acerca un paso más un potencial tratamiento contra el Parkinson

English Por: Charlene N. Rivera Bonet, Escritora Científica, Waisman Center Más de dos décadas de investigación fundamental de la enfermedad de Parkinson dirigida por Su-Chun Zhang, MD, PhD, profesor de neurociencia y neurología en la Universidad de Wisconsin-Madison e investigador en Waisman, han culminado en el desarrollo de un tratamiento prometedor basado en células madre. …

Pioneering research brings potential Parkinson’s disease treatment one step closer

Over two decades of fundamental research in Parkinson’s disease led by Su-Chun Zhang, MD, PhD, professor of neuroscience and neurology at the University of Wisconsin-Madison and Waisman investigator, has culminated in the development of a promising stem cell-based treatment for the disease.